Kanawha Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.66M | Sell |
13,827
-201
| -1% | -$23.2K | 0.12% | 102 |
|
|
2025
Q4 | $1.48M | Sell |
14,028
-1
| -0% | -$94 | 0.1% | 103 |
|
|
2025
Q3 | $1.18M | Buy |
14,029
+150
| +1% | +$12.4K | 0.08% | 112 |
|
|
2025
Q2 | $1.1M | Sell |
13,879
-1,866
| -12% | -$148K | 0.08% | 114 |
|
|
2025
Q1 | $1.41M | Sell |
15,745
-3,334
| -17% | -$311K | 0.11% | 102 |
|
|
2024
Q4 | $1.9M | Buy |
19,079
+17
| +0.1% | +$1.75K | 0.15% | 93 |
|
|
2024
Q3 | $2.16M | Sell |
19,062
-3,244
| -15% | -$385K | 0.16% | 92 |
|
|
2024
Q2 | $2.76M | Buy |
22,306
+4,284
| +24% | +$552K | 0.22% | 84 |
|
|
2024
Q1 | $2.38M | Sell |
18,022
-334
| -2% | -$41.2K | 0.19% | 91 |
|
|
2023
Q4 | $2M | Sell |
18,356
-3,607
| -16% | -$374K | 0.18% | 85 |
|
|
2023
Q3 | $2.26M | Buy |
21,963
+259
| +1% | +$27.9K | 0.22% | 80 |
|
|
2023
Q2 | $2.5M | Buy |
21,704
+318
| +1% | +$36.1K | 0.23% | 78 |
|
|
2023
Q1 | $2.28M | Sell |
21,386
-441
| -2% | -$47.6K | 0.22% | 79 |
|
|
2022
Q4 | $2.42M | Buy |
21,827
+1,041
| +5% | +$106K | 0.24% | 77 |
|
|
2022
Q3 | $1.79M | Buy |
20,786
+1,232
| +6% | +$110K | 0.2% | 83 |
|
|
2022
Q2 | $1.78M | Buy |
19,554
+16
| +0.1% | +$1.42K | 0.18% | 85 |
|
|
2022
Q1 | $1.6M | Sell |
19,538
-2,823
| -13% | -$223K | 0.14% | 94 |
|
|
2021
Q4 | $1.71M | Hold |
22,361
| – | – | 0.14% | 89 |
|
|
2021
Q3 | $1.68M | Sell |
22,361
-2,001
| -8% | -$152K | 0.16% | 91 |
|
|
2021
Q2 | $1.9M | Sell |
24,362
-1,274
| -5% | -$94.8K | 0.17% | 88 |
|
|
2021
Q1 | $1.89M | Hold |
25,636
| – | – | 0.18% | 83 |
|
|
2020
Q4 | $2M | Buy |
25,636
+316
| +1% | +$24.2K | 0.21% | 80 |
|
|
2020
Q3 | $2M | Buy |
25,320
+60
| +0.2% | +$4.7K | 0.23% | 76 |
|
|
2020
Q2 | $1.86M | Sell |
25,260
-91
| -0.4% | -$6.85K | 0.23% | 77 |
|
|
2020
Q1 | $1.86M | Buy |
25,351
+422
| +2% | +$33.2K | 0.27% | 73 |
|
|
2019
Q4 | $2.16M | Buy |
24,929
+3,417
| +16% | +$281K | 0.25% | 78 |
|
|
2019
Q3 | $1.73M | Buy |
21,512
+1,687
| +9% | +$135K | 0.22% | 77 |
|
|
2019
Q2 | $1.59M | Sell |
19,825
-1,079
| -5% | -$82.6K | 0.21% | 81 |
|
|
2019
Q1 | $1.66M | Buy |
20,904
+1,101
| +6% | +$82.3K | 0.23% | 77 |
|
|
2018
Q4 | $1.44M | Buy |
19,803
+891
| +5% | +$62.9K | 0.23% | 76 |
|
|
2018
Q3 | $1.28M | Buy |
18,912
+577
| +3% | +$36.8K | 0.18% | 83 |
|
|
2018
Q2 | $1.06M | Hold |
18,335
| – | – | 0.16% | 92 |
|
|
2018
Q1 | $953K | Sell |
18,335
-246
| -1% | -$13.3K | 0.14% | 91 |
|
|
2017
Q4 | $998K | Sell |
18,581
-461
| -2% | -$25.6K | 0.15% | 92 |
|
|
2017
Q3 | $1.16M | Sell |
19,042
-681
| -3% | -$41.3K | 0.18% | 91 |
|
|
2017
Q2 | $1.21M | Sell |
19,723
-2,032
| -9% | -$124K | 0.19% | 86 |
|
|
2017
Q1 | $1.32M | Buy |
21,755
+389
| +2% | +$23.6K | 0.21% | 84 |
|
|
2016
Q4 | $1.2M | Sell |
21,366
-4,086
| -16% | -$239K | 0.2% | 87 |
|
|
2016
Q3 | $1.52M | Sell |
25,452
-146
| -0.6% | -$8.54K | 0.25% | 81 |
|
|
2016
Q2 | $1.41M | Sell |
25,598
-60
| -0.2% | -$3.19K | 0.24% | 84 |
|
|
2016
Q1 | $1.29M | Sell |
25,658
-599
| -2% | -$29.3K | 0.22% | 81 |
|
|
2015
Q4 | $1.32M | Sell |
26,257
-1,664
| -6% | -$83.9K | 0.24% | 81 |
|
|
2015
Q3 | $1.32M | Buy |
27,921
+457
| +2% | +$24.3K | 0.25% | 83 |
|
|
2015
Q2 | $1.49M | Buy |
27,464
+1,358
| +5% | +$76.2K | 0.26% | 86 |
|
|
2015
Q1 | $1.43M | Sell |
26,106
-2,723
| -9% | -$154K | 0.25% | 86 |
|
|
2014
Q4 | $1.56M | Hold |
28,829
| – | – | 0.27% | 83 |
|
|
2014
Q3 | $1.63M | Buy |
28,829
+184
| +0.6% | +$10.3K | 0.3% | 83 |
|
|
2014
Q2 | $1.58M | Buy |
28,645
+53
| +0.2% | +$2.89K | 0.29% | 84 |
|
|
2014
Q1 | $1.55M | Hold |
28,592
| – | – | 0.29% | 83 |
|
|
2013
Q4 | $1.36M | Buy |
28,592
+2
| +0% | +$91 | 0.26% | 84 |
|
|
2013
Q3 | $1.3M | Sell |
28,590
-262
| -0.9% | -$12K | 0.27% | 85 |
|
|
2013
Q2 | $1.28M | Buy |
+28,852
| New | +$1.29M | 0.28% | 83 |
|
Other funds holding MRK
VCM
VPM
Kanawha Capital Management's MRK Position: Q1 2026 in Review
Kanawha Capital Management reduced its Merck (MRK) stake by 1.4% in Q1 2026, selling an estimated $23.2K and leaving 13,827 shares worth $1.66M. The position accounts for 0.12% of the portfolio, ranked #102.
Kanawha Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.76M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Kanawha Capital Management held 13,827 shares of Merck worth $1.66M as of Q1 2026.
- Kanawha Capital Management sold 201 Merck shares in Q1 2026, an estimated $23.2K.
- Merck made up 0.12% of Kanawha Capital Management's portfolio in Q1 2026, its #102 holding.
- Kanawha Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Kanawha Capital Management's Merck position peaked at $2.76M in Q2 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Kanawha Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.